Select a Sector or Industry
Gross Profit Margin Rankings for Drug Manufacturers - Other Industry
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Rank | Symbol | Company |
Gross Profit Margin
|
Pro Rating
|
|---|---|---|---|---|
| 1 | DEPO | Depomed | 96.92% | Go Pro |
| 2 | DRRX | Durect Corporation | 96.45% | Go Pro |
| 3 | SOMX | Somaxon Pharmaceuticals | 90.00% | Go Pro |
| 4 | WCRX | Warner Chilcott | 89.49% | Go Pro |
| 5 | UTHR | United Therapeutics Corporation | 88.23% | Go Pro |
| 6 | SCLN | SciClone Pharmaceuticals | 87.38% | Go Pro |
| 7 | AGN | Allergan | 85.93% | Go Pro |
| 8 | DUSA | DUSA Pharmaceuticals | 84.58% | Go Pro |
| 9 | ALTH | Allos Therapeutics | 84.06% | Go Pro |
| 10 | SCR | Simcere Pharmaceutical Group | 81.03% | Go Pro |
| 11 | NVO | Novo Nordisk | 81.00% | Go Pro |
| 12 | FRX | Forest Laboratories | 79.39% | Go Pro |
| 13 | CBST | Cubist Pharmaceuticals | 74.51% | Go Pro |
| 14 | TARO | Taro Pharmaceutical Industries | 71.59% | Go Pro |
| 15 | MDCO | The Medicines Company | 69.46% | Go Pro |
| 16 | PTX | Pernix Therapeutics | 67.61% | Go Pro |
| 17 | GENT | Gentium | 67.24% | Go Pro |
| 18 | RDY | Dr. Reddy's Laboratories | 59.77% | Go Pro |
| 19 | ENDP | Endo Health Solutions | 47.18% | Go Pro |
| 20 | LCI | Lannett Company | 35.49% | Go Pro |
| 21 | TPI | Tianyin Pharmaceutical | 33.43% | Go Pro |
| 22 | APRI | Nexmed | 15.97% | Go Pro |
